CivaSheet
Commercial- Indications
- Pancreatic cancer, Soft tissue sarcoma, Head and neck cancer, Lung cancer, Colorectal cancer
Company intelligence / Profile preview
CivaTech Oncology
Durham / Research Triangle Park, North Carolina, United Statescivatechoncology.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
CivaTech Oncology has developed and commercialized FDA-cleared, polymer-based low-dose-rate brachytherapy devices—CivaSheet® and CivaString®—for the treatment of localized solid tumors. Clinical results show significant improvements in disease-free survival for pancreatic cancer patients using CivaSheet®, with reduced procedure time, minimized trauma, improved quality of life, and lower toxicity compared to traditional methods. Over 25 clinics are using these products commercially or in research settings
- Therapeutic areas
- Oncology
- Modalities
- DeviceRadiopharmaceutical (palladium-based brachytherapy sources)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
National Cancer Institute/National Institutes of Health SBIR program support
Beyond the preview
Go deeper on CivaTech Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CivaTech Oncology.